Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Abstract
We recently reported that differentiation of CD8(+) T cells from the naïve to the effector state involves the upregulation of glucose-dependent metabolism. Glucose deprivation or inhibition of glycolysis by 2-deoxy-D-glucose (2-DG) selectively inhibited production of IFN-gamma but not of IL-2. To determine a more global role of glucose metabolism on effector T-cell function, we performed gene array analysis on CD8(+) effector T cells stimulated in the presence or absence of 2-DG. We observed that expression of only 10% of genes induced by TCR/CD28 signaling was inhibited by 2-DG. Among these were genes for key cytokines, cell cycle molecules, and cytotoxic granule proteins. Consistent with these results, production of IFN-gamma and GM-CSF, cell cycle progression, upregulation of cyclin D2 protein, cytolytic activity, and upregulation of granzyme B protein and also conjugate formation were exquisitely glucose-dependent. In contrast to glucose, oxygen was little utilized by CD8(+) effector T cells, and relative oxygen deprivation did not inhibit these CTL functional properties. Our results indicate a particularly critical role for glucose in regulating specific effector functions of CD8(+) T cells and have implications for the maintenance of the effector phase of cellular immune responses in target tissue microenvironments such as a solid tumor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Reduction in mTOR activity diminishes IFNγ transcripts in T cells, mitigating Th1 CD4+ T cell differentiation [227, 228, 229].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [227]
In the citing paper
“Limiting glucose levels leads to cellular competition; this impairs T‐cell function via decreased mTOR signaling.”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [227]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., & Riccardi, C. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90198-o · Cited by 4,579 · cited 1×
“To determine which phase of the cell cycle is blocked by 2-DG, we examined the DNA content of stimulated effector cells by PI staining (Nicoletti assay) [6].”
MethodModel-based analysis of oligonucleotide arrays: Expression index computation and outlier detection.
Li, C., & Wong, W. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.31 · Cited by 3,133 · cited 1×
“Subsequent data analysis involved: i) the normalization of array values by dCHIP software [29], ii) the averaging of two independent samples for each experiment, iii) determining relative expression using normalized values in a Microsoft Excel spreadsheet.”
MethodThree-dimensional segregation of supramolecular activation clusters in T cells
Monks, C. R. F., Freiberg, B. A., Kupfer, H., Sciaky, N., & Kupfer, A. (1998) · Nature · doi:10.1038/25764 · Cited by 1,968 · cited 1×
“In addition, the mature synapse in many systems includes central clearing of talin and partitioning of signaling molecules such as PKC-θ in the central supramolecular activation cluster (cSMAC) [5].”
BackgroundAMP-activated protein kinase induces a p53-dependent metabolic checkpoint
Jones, R. G., Plas, D. R., Kubek, S., Buzzai, M., Mu, J., Xu, Y., Birnbaum, M. J., & Thompson, C. B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.027 · Cited by 1,619
The Role of Oxidative Stress in Carcinogenesis
Klaunig, J. E., & Kamendulis, L. M. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121851 · Cited by 1,533 · cited 1×
“It is well-established that ROS induce DNA damage and can lead to aberrant activation of AP-1 and NF-κB [22].”
BackgroundMolecular and Functional Profiling of Memory CD8 T Cell Differentiation
Kaech, S. M., Hemby, S., Kersh, E., & Ahmed, R. (2002) · Cell · doi:10.1016/s0092-8674(02)01139-x · Cited by 982 · cited 1×
“expression of glycolytic enzyme genes in effector and memory T cells analyzed ex vivo [20].”
BackgroundFuel feeds function: energy metabolism and the T-cell response
Fox, C. J., Hammerman, P. S., & Thompson, C. B. (2005) · Nature Reviews Immunology · doi:10.1038/nri1710 · Cited by 853 · cited 1×
“The role of cell metabolism in T cell responsiveness to TCR/CD28 ligation has recently been reviewed [3].”
BackgroundThe Immunological Synapse of CTL Contains a Secretory Domain and Membrane Bridges
Stinchcombe, J. C., Bossi, G., Booth, S., & Griffiths, G. M. (2001) · Immunity · doi:10.1016/s1074-7613(01)00234-5 · Cited by 814
Localization of the primary metabolic block produced by 2-deoxyglucose
Wick, A. N., Drury, D. R., Nakada, H. I., Wolfe, J. B., Britton, B., & Grabowski, R. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64988-9 · Cited by 780 · cited 1×
“5-SHG and 2-DG are both competitive inhibitors of glucose for the glycolytic proteins hexokinase, phosphoglucoisomerase, and phosphoglucomutase [8,9].”
BackgroundRegulation of immune cells by local-tissue oxygen tension: HIF1α and adenosine receptors
Sitkovsky, M., & Lukashev, D. (2005) · Nature Reviews Immunology · doi:10.1038/nri1685 · Cited by 518 · cited 1×
“Hypoxic conditions are known to induce upregulation of HIF-1α, which promotes expression of genes encoding glycolytic enzymes but also has other physiologic targets [17].”
Background
Cited by
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chang, C.-H., Qiu, J., O’Sullivan, D., Buck, M. D., Noguchi, T., Curtis, J. D., Chen, Q., Gindin, M., Gubin, M. M., van der Windt, G. J. W., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.016 · Cited by 3,331
“Aerobic glycolysis is required for optimal T cell effector function (Cham et al., 2008), but not for activation, proliferation, or survival (Chang et al., 2013).”
BackgroundPosttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chang, C.-H., Curtis, J. D., Maggi, L. B., Faubert, B., Villarino, A. V., O’Sullivan, D., Huang, S. C.-C., van der Windt, G. J. W., Blagih, J., Qiu, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.016 · Cited by 2,204
“Previous studies demonstrated that T cells culturedwithout sugar have severe defects (Cham et al., 2008; Cham and Gajewski, 2005; Tripmacher et al., 2008).”
Shi, L. Z., Wang, R., Huang, G., Vogel, P., Neale, G., Green, D. R., & Chi, H. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110278 · Cited by 1,803
“In support of this notion, proper regulation of glucose and sterol metabolism is required for the development of adaptive immune responses (Bensinger and Tontonoz, 2008; Bensinger et al., 2008; Cham et al., 2008).”
BackgroundHypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions
Chen, Z., Han, F., Du, Y., Shi, H., & Zhou, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01332-8 · Cited by 1,612
“Relatively high levels of exogenous glucose are required to maintain the CTL transcriptional program.(219,220) HIF-1α enhances the glycolytic activity of but not HIF-2α.”
BackgroundPhosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
Ho, P.-C., Bihuniak, J. D., Macintyre, A. N., Staron, M., Liu, X., Amezquita, R., Tsui, Y.-C., Cui, G., Micevic, G., Perales, J. C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.012 · Cited by 1,462
“…aerobic glycolysis is essential for the production of biosynthetic precursors that fuel effector T cell proliferation and production of effector molecules like IFNg, IL-2, and IL-17 and Granzyme B in T cells (Cham et al., 2008; Chang et al., 2013; Finlay et al., 2012; Michalek et al., 2011).”
BackgroundMetabolic Instruction of Immunity
Buck, M. D., Sowell, R. T., Kaech, S. M., & Pearce, E. L. (2017) · Cell · doi:10.1016/j.cell.2017.04.004 · Cited by 1,214
“Glucose deprivation represses Ca2+ signaling, IFN-γ production, cytotoxicity, and motility in T cells and pro-inflammatory functions in macrophages (Cham et al., 2008; Chang et al., 2013; Chang et al., 2015; Macintyre et al., 2014).”
T cell metabolism drives immunity
Buck, M. D., O’Sullivan, D., & Pearce, E. L. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20151159 · Cited by 1,179
“When deprived of glucose, CD8 T cells display defects in functional capacity with reduced IFN-, granzyme, and perforin production (Cham and Gajewski, 2005; Cham et al., 2008; Jacobs et al., 2008).”
BackgroundInhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function
Sukumar, M., Liu, J., Ji, Y., Subramanian, M., Crompton, J. G., Yu, Z., Roychoudhuri, R., Palmer, D. C., Muranski, P., Karoly, E. D., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69589 · Cited by 952
“To directly target the glycolytic pathway in CD8 + T cells, we used the Hk2 inhibitor 2DG. Previous reports have demonstrated that cell proliferation was blocked by high concentrations of 2DG (50 mM) (36).”
Metabolism of immune cells in cancer
Leone, R. D., & Powell, J. D. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0273-y · Cited by 877
Wang, T., Fahrmann, J. F., Lee, H., Li, Y.-J., Tripathi, S. C., Yue, C., Zhang, C., Lifshitz, V., Song, J., Yuan, Y., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.001 · Cited by 825
Regulatory mechanisms of PD-1/PD-L1 in cancers
Lin, X., Kang, K., Chen, P., Zeng, Z., Li, G., Xiong, W., Yi, M., & Xiang, B. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02023-w · Cited by 784
Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies
Anderson, K. G., Stromnes, I. M., & Greenberg, P. D. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.02.008 · Cited by 702
Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity
Kornberg, M. D., Bhargava, P., Kim, P. M., Putluri, V., Snowman, A. M., Putluri, N., Calabresi, P. A., & Snyder, S. H. (2018) · Science · doi:10.1126/science.aan4665 · Cited by 687
Trompette, A., Gollwitzer, E. S., Pattaroni, C., Lopez-Mejia, I. C., Riva, E., Pernot, J., Ubags, N., Fajas, L., Nicod, L. P., & Marsland, B. J. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.022 · Cited by 678
“The functional capacity of CD8+ T cells is largely dependent on glucose availability and uptake (Cham et al., 2008; Jacobs et al., 2008).”
BackgroundThe Energy Sensor AMPK Regulates T Cell Metabolic Adaptation and Effector Responses In Vivo
Blagih, J., Coulombe, F., Vincent, E. E., Dupuy, F., Galicia-Vázquez, G., Yurchenko, E., Raissi, T. C., van der Windt, G. J. W., Viollet, B., Pearce, E. L., et al. (2015) · Immunity · doi:10.1016/j.immuni.2014.12.030 · Cited by 664
“Consequently, reduced nutrient availability during early activation impairs interferon-g (IFN-g) production by CD4 and CD8 Teff cells in vitro (Cham et al., 2008; Cham and Gajewski, 2005; Chang et al., 2013).”
BackgroundMetabolites and the Tumour Microenvironment: From Cellular Mechanisms to Systemic Metabolism
Elia, I., & Haigis, M. C. (2021) · Nature Metabolism · doi:10.1038/s42255-020-00317-z · Cited by 651
Glycolysis – a key player in the inflammatory response
Soto‐Heredero, G., Gómez de las Heras, M. M., Gabandé‐Rodríguez, E., Oller, J., & Mittelbrunn, M. (2020) · The FEBS Journal · doi:10.1111/febs.15327 · Cited by 641
Mechanisms and Implications of Metabolic Heterogeneity in Cancer
Kim, J., & DeBerardinis, R. J. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.013 · Cited by 606
Finlay, D. K., Rosenzweig, E., Sinclair, L. V., Feijoo-Carnero, C., Hukelmann, J. L., Rolf, J., Panteleyev, A. A., Okkenhaug, K., & Cantrell, D. A. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112607 · Cited by 596
“MaxQuant version 1.3.0.5 (Cox and Mann, 2008) was used to process raw MS spectra, using the default settings against the mice Uniprot database (July 2012).”
MethodInfluentialMolecular regulation of effector and memory T cell differentiation
Chang, J. T., Wherry, E. J., & Goldrath, A. W. (2014) · Nature Immunology · doi:10.1038/ni.3031 · Cited by 582
Metabolic switching and fuel choice during T‐cell differentiation and memory development
van der Windt, G. J. W., & Pearce, E. L. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01150.x · Cited by 563
“Also, in the absence of glucose, CD8 T cells have a defect in cytolytic activity marked by reduced granzyme and perforin production (19).”
BackgroundCaro-Maldonado, A., Wang, R., Nichols, A. G., Kuraoka, M., Milasta, S., Sun, L. D., Gavin, A. L., Abel, E. D., Kelsoe, G., Green, D. R., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302062 · Cited by 549
“Glucose deprivation (3, 12, 13), or treatment with the glycolytic inhibitor, 2-deoxyglucose (2-DG) (5, 14, 15), suppresses T cell activation, proliferation, and production of IFN-g.”
BackgroundNK Cell Metabolism and Tumor Microenvironment
Terrén, I., Orrantia, A., Vitallé, J., Zenarruzabeitia, O., & Borrego, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02278 · Cited by 501
“It has been demonstrated that glucose deprivation dampens T cell antitumor activity (46, 55, 56), and that metabolic competition in the TME can regulate cancer progression by impairing antigen-specific responses of tumorinfiltrating T cells (57).”
BackgroundThe Mammalian Target of Rapamycin: Linking T Cell Differentiation, Function, and Metabolism
Powell, J. D., & Delgoffe, G. M. (2010) · Immunity · doi:10.1016/j.immuni.2010.09.002 · Cited by 486
Fates of CD8+ T cells in Tumor Microenvironment
Maimela, N. R., Liu, S., & Zhang, Y. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2018.11.004 · Cited by 459
“T cells in the circulatory system need to firstly bind themselves to the ECs, move along ECs towards the tumor site, firmly grip to the endothelial wall, and lastly bridge through the endothelial wall of the blood vessel in order to enter the infection or tumor site [12,50].”
BackgroundMetabolism of stromal and immune cells in health and disease
Ghesquière, B., Wong, B. W., Kuchnio, A., & Carmeliet, P. (2014) · Nature · doi:10.1038/nature13312 · Cited by 451
The spectrum of T cell metabolism in health and disease
Bantug, G. R., Galluzzi, L., Kroemer, G., & Hess, C. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.99 · Cited by 415
Metabolism of pancreatic cancer: paving the way to better anticancer strategies
Qin, C., Yang, G., Yang, J., Ren, B., Wang, H., Chen, G., Zhao, F., You, L., Wang, W., & Zhao, Y. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01169-7 · Cited by 413
mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation
Pollizzi, K. N., Patel, C. H., Sun, I.-H., Oh, M.-H., Waickman, A. T., Wen, J., Delgoffe, G. M., & Powell, J. D. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77746 · Cited by 411
Integrating canonical and metabolic signalling programmes in the regulation of T cell responses
Pollizzi, K. N., & Powell, J. D. (2014) · Nature Reviews Immunology · doi:10.1038/nri3701 · Cited by 379
Metabolites as signalling molecules
Baker, S. A., & Rutter, J. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00572-w · Cited by 368
Ma, E. H., Verway, M. J., Johnson, R. M., Roy, D. G., Steadman, M., Hayes, S., Williams, K. S., Sheldon, R. D., Samborska, B., Kosinski, P. A., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.09.003 · Cited by 372
“, 2016), and glucose and glutamine (Blagih et al., 2015; Cham et al., 2008; Chang et al., 2013).”
BackgroundSimilarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors
Andrejeva, G., & Rathmell, J. C. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.004 · Cited by 373
“Glucose limitation or inhibition of glycolysis by 2-deoxyglucose in CD8 T cells resulted in reduced cytolytic activity and diminished production of IFNg, granzyme B, and GM-CSF (Cham and Gajewski, 2005; Cham et al., 2008).”
BackgroundZhang, C., Yue, C., Herrmann, A., Song, J., Egelston, C., Wang, T., Zhang, Z., Li, W., Lee, H., Aftabizadeh, M., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.10.013 · Cited by 366
“Although CD8+ central memory T (TCM) cells are known to utilize FAO as an energy source for survival, CD8+ TEFF cells depend on aerobic glycolysis for their effector functions (Cham et al., 2008; Chang et al., 2013; Lochner et al., 2015).”
BackgroundUnraveling the crosstalk between melanoma and immune cells in the tumor microenvironment
Marzagalli, M., Ebelt, N. D., & Manuel, E. R. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.002 · Cited by 345
Manzo, T., Prentice, B. M., Anderson, K. G., Raman, A., Schalck, A., Codreanu, G. S., Nava Lauson, C. B., Tiberti, S., Raimondi, A., Jones, M. A., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20191920 · Cited by 342
“When deprived of glucose, CD8 + T cells are compromised in their ability to produce effector cytokines (Cham et al., 2008; Cham and Gajewski, 2005; Jacobs et al., 2008).”
Acetate Promotes T Cell Effector Function during Glucose Restriction
Qiu, J., Villa, M., Sanin, D. E., Buck, M. D., O’Sullivan, D., Ching, R., Matsushita, M., Grzes, K. M., Winkler, F., Chang, C.-H., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.022 · Cited by 342
Zhong, X., He, X., Wang, Y., Hu, Z., Huang, H., Zhao, S., Wei, P., & Li, D. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01358-5 · Cited by 329
“C and Cyclin D2, indicating that the anti-tumor function of CD8 + T cell was significantly impaired in a glucose-deprived environment [209].”
BackgroundMechanisms of action and rationale for the use of checkpoint inhibitors in cancer
Granier, C., De Guillebon, E., Blanc, C., Roussel, H., Badoual, C., Colin, E., Saldmann, A., Gey, A., Oudard, S., & Tartour, E. (2017) · ESMO Open · doi:10.1136/esmoopen-2017-000213 · Cited by 324
Tumor microenvironment signaling and therapeutics in cancer progression
Goenka, A., Khan, F., Verma, B., Sinha, P., Dmello, C. C., Jogalekar, M. P., Gangadaran, P., & Ahn, B. (2023) · Cancer Communications · doi:10.1002/cac2.12416 · Cited by 323
T cell metabolic fitness in antitumor immunity
Siska, P. J., & Rathmell, J. C. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.007 · Cited by 312
Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma
Chen, C., Wang, Z., Ding, Y., & Qin, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1133308 · Cited by 305
Targeting metabolism to regulate immune responses in autoimmunity and cancer
Patel, C. H., Leone, R. D., Horton, M. R., & Powell, J. D. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0032-5 · Cited by 306
Oncometabolite d -2HG alters T cell metabolism to impair CD8 + T cell function
Notarangelo, G., Spinelli, J. B., Perez, E. M., Baker, G. J., Kurmi, K., Elia, I., Stopka, S. A., Baquer, G., Lin, J.-R., Golby, A. J., et al. (2022) · Science · doi:10.1126/science.abj5104 · Cited by 289
Leptin Metabolically Licenses T Cells for Activation To Link Nutrition and Immunity
Saucillo, D. C., Gerriets, V. A., Sheng, J., Rathmell, J. C., & MacIver, N. J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301158 · Cited by 282
“Moreover, activated effector T cells rely on glucose availability, glucose uptake, and aerobic glycolysis to survive and function properly (5, 8).”
BackgroundTherapeutic Cancer Vaccines: Current Status and Moving Forward
Schlom, J. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs033 · Cited by 282
Anergic T Cells Are Metabolically Anergic
Zheng, Y., Delgoffe, G. M., Meyer, C. F., Chan, W., & Powell, J. D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803510 · Cited by 279
Macintyre, A. N., Finlay, D., Preston, G., Sinclair, L. V., Waugh, C. M., Tamas, P., Feijoo, C., Okkenhaug, K., & Cantrell, D. A. (2011) · Immunity · doi:10.1016/j.immuni.2011.01.012 · Cited by 273
“The coordination of glucose metabolism is essential for T cell activation (Cham et al., 2008; Maciver et al., 2008) and this function might be controlled by PI3K-Akt.”
BackgroundTGF-β signaling in the tumor metabolic microenvironment and targeted therapies
Shi, X., Yang, J., Deng, S., Xu, H., Wu, D., Zeng, Q., Wang, S., Hu, T., Wu, F., & Zhou, H. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01349-6 · Cited by 262
“A similar phenomenon was also observed in CD8 + T cells [231, 232].”
ResultChallenges and new technologies in adoptive cell therapy
Zhang, P., Zhang, G., & Wan, X. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01492-8 · Cited by 259
“It has been shown that T cell differentiation can be controlled by glycolysis and OxPhos or FAO pathways [236, 237].”
BackgroundTargeting T cell metabolism for therapy
O'Sullivan, D., & Pearce, E. L. (2015) · Trends in Immunology · doi:10.1016/j.it.2014.12.004 · Cited by 254
Li, L., Liu, X., Sanders, K. L., Edwards, J. L., Ye, J., Si, F., Gao, A., Huang, L., Hsueh, E. C., Ford, D. A., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.020 · Cited by 245
Hudson, K., Cross, N., Jordan-Mahy, N., & Leyland, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.568931 · Cited by 243
“Metabolic Processes Within the tumor microenvironment, nutrient competition between tumor cells and immune cells may regulate tumor progression and PD-L1 has been reported to directly regulate the metabolism of several cancer cell lines (190, 191).”
BackgroundThe liver kinase B1 is a central regulator of T cell development, activation, and metabolism
MacIver, N. J., Blagih, J., Saucillo, D. C., Tonelli, L., Griss, T., Rathmell, J. C., & Jones, R. G. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100367 · Cited by 235
Yang, L., He, Y.-T., Dong, S., Wei, X.-W., Chen, Z.-H., Zhang, B., Chen, W.-D., Yang, X.-R., Wang, F., Shang, X.-M., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003534 · Cited by 232
Quantitative analysis of T cell proteomes and environmental sensors during T cell differentiation
Howden, A. J. M., Hukelmann, J. L., Brenes, A., Spinelli, L., Sinclair, L. V., Lamond, A. I., & Cantrell, D. A. (2019) · Nature Immunology · doi:10.1038/s41590-019-0495-x · Cited by 231
Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications
Gandhi, N., & Das, G. (2019) · Cells · doi:10.3390/cells8020089 · Cited by 227
“Aerobic glycolysis is required for optimal T-cell function but is not important for its proliferation or survival [171,172].”
BackgroundMetabolism, migration and memory in cytotoxic T cells
Finlay, D., & Cantrell, D. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri2888 · Cited by 225
“It is thus essential that CD8 + T cells can increase cellular energy production and nutrient uptake to satisfy increased biosynthetic demands as and when they occu”
BackgroundMetabolism of activated T lymphocytes
Maciolek, J. A., Alex Pasternak, J., & Wilson, H. L. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.01.006 · Cited by 224
“Murine anti-CD3/ CD28 stimulated CD8 T cells were shown to be strongly dependent upon glucose for fuel, as glucose deprivation strongly inhibited IFN-g gene expression, cell cycle progression, catalytic activity, and upregulation of granzyme B protein production [95 ,96].”
BackgroundMetabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy
Gupta, S., Roy, A., & Dwarakanath, B. S. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00068 · Cited by 218
mTOR Regulation of Glycolytic Metabolism in T Cells
Salmond, R. J. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00122 · Cited by 211
“Furthermore, studies indicated that 2-DG treatment selectively reduced the expression of key effector molecules, including IFNγ and granzymes, and cell cycle proteins in both mouse (Cham and Gajewski, 2005; Cham et al., 2008) and human (Renner et al., 2015) CD8+ T cells.”
BackgroundMetabolic Barriers to T Cell Function in Tumors
Sugiura, A., & Rathmell, J. C. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701041 · Cited by 208
“TCR signaling, proliferation, and cytokine production (10, 11, 13, 55).”
BackgroundLopes, N., McIntyre, C., Martin, S., Raverdeau, M., Sumaria, N., Kohlgruber, A. C., Fiala, G. J., Agudelo, L. Z., Dyck, L., Kane, H., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00848-3 · Cited by 197
Metabolic Modulation of Immunity: A New Concept in Cancer Immunotherapy
Guerra, L., Bonetti, L., & Brenner, D. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107848 · Cited by 189
Tumor Microenvironment: A Metabolic Player that Shapes the Immune Response
Cassim, S., & Pouyssegur, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010157 · Cited by 188
Nutritional effects on T‐cell immunometabolism
Cohen, S., Danzaki, K., & MacIver, N. J. (2017) · European Journal of Immunology · doi:10.1002/eji.201646423 · Cited by 187
Nicolini, A., & Ferrari, P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1353787 · Cited by 182
“…hypoxia and mTORC1 signaling inhibition, due to limited glucose availability, there is hypo-expression of antigen-inducing genes, decreased proliferation, and diminished function of CD8+ cell (66, 67), as well as apoptosis of Teff cells triggered by the activation of pro-apoptotic genes/proteins.”
BackgroundGlucose, glycolysis and lymphocyte responses
Donnelly, R. P., & Finlay, D. K. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.07.034 · Cited by 182
Preventing Allograft Rejection by Targeting Immune Metabolism
Lee, C.-F., Lo, Y.-C., Cheng, C.-H., Furtmüller, G. J., Oh, B., Andrade-Oliveira, V., Thomas, A. G., Bowman, C. E., Slusher, B. S., Wolfgang, M. J., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.036 · Cited by 177
“Essential for this activation-induced glycolytic response is glucose uptake (Cham et al., 2008; Cham and Gajewski, 2005).”
BackgroundMetabolic reprogramming and metabolic dependency in T cells
Wang, R., & Green, D. R. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01155.x · Cited by 176
“ditions display compromised IFNc but not IL2 production, implicating a requirement for glucose catabolism for this aspect of CD8 T-cell effector function (40, 41).”
BackgroundReinforce the antitumor activity of CD 8+ T cells via glutamine restriction
Nabe, S., Yamada, T., Suzuki, J., Toriyama, K., Yasuoka, T., Kuwahara, M., Shiraishi, A., Takenaka, K., Yasukawa, M., & Yamashita, M. (2018) · Cancer Science · doi:10.1111/cas.13827 · Cited by 175
Palmer, C. S., Ostrowski, M., Gouillou, M., Tsai, L., Yu, D., Zhou, J., Henstridge, D. C., Maisa, A., Hearps, A. C., Lewin, S. R., et al. (2014) · AIDS · doi:10.1097/qad.0000000000000128 · Cited by 170
“Several immune functions with relevance to HIV infection depend on adequate glucose supply, including T-cell activation [2], T-cell-mediated antiviral responses, andotherT-cell effector functions [1,3].”
BackgroundCounteracting CAR T cell dysfunction
Poorebrahim, M., Melief, J., Pico de Coaña, Y., L. Wickström, S., Cid-Arregui, A., & Kiessling, R. (2021) · Oncogene · doi:10.1038/s41388-020-01501-x · Cited by 168
Effects of altered glycolysis levels on CD8+ T cell activation and function
Cao, J., Liao, S., Zeng, F., Liao, Q., Luo, G., & Zhou, Y. (2023) · Cell Death & Disease · doi:10.1038/s41419-023-05937-3 · Cited by 163
“Under hypoxic pressure culture conditions, upregulation of the levels of glycolytic pathway-related proteins such as GLUT1 and GLUT3 in memory CD8+ T cells lead to an increase in glycolysis level, thereby promoting their effector functions of IFN-γ and granzyme B production, but the ability of producing TNF-α and IL-2…”
BackgroundInfluentialDysfunctional T cell metabolism in the tumor microenvironment
Beckermann, K. E., Dudzinski, S. O., & Rathmell, J. C. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.04.003 · Cited by 159
Microenvironmental Metabolism Regulates Antitumor Immunity
Ngwa, V. M., Edwards, D. N., Philip, M., & Chen, J. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0617 · Cited by 171
Gemta, L. F., Siska, P. J., Nelson, M. E., Gao, X., Liu, X., Locasale, J. W., Yagita, H., Slingluff, C. L., Hoehn, K. L., Rathmell, J. C., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aap9520 · Cited by 155
Mitochondrial Metabolism Regulation of T Cell–Mediated Immunity
Steinert, E. M., Vasan, K., & Chandel, N. S. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101819-082015 · Cited by 173
Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer
Wang, Y., Wang, Y., Ren, Y., Zhang, Q., Yi, P., & Cheng, C. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.02.010 · Cited by 153
The immunologic Warburg effect: Evidence and therapeutic opportunities in autoimmunity
Kornberg, M. D. (2020) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1486 · Cited by 163
“Soon after, Cham and colleagues (Cham et al., 2008; Cham & Gajewski, 2005) showed that this coordinated glycolytic reprogramming is required for CD8 effector functions such as cytokine transcription and cytolytic activity, which were inhibited by glucose deprivation and the glycolysis inhibitor…”
BackgroundExtracellular acidosis restricts one-carbon metabolism and preserves T cell stemness
Cheng, H., Qiu, Y., Xu, Y., Chen, L., Ma, K., Tao, M., Frankiw, L., Yin, H., Xie, E., Pan, X., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-022-00730-6 · Cited by 163
Dietary intervention in acne: Attenuation of increased mTORC1 signaling promoted by Western diet
Melnik, B. (2012) · Dermato-Endocrinology · doi:10.4161/derm.19828 · Cited by 142
“Similarly, the glucose analog 2-deoxyglucose (2DG) inhibited mTORC1 function most likely via the AMPK pathway and promoted T cell anergy.(92) Furthermore, the AMPK activator AICAR inhibited mTORC1 and T cell function and mitigated experimental autoimmune encephalomyelitis.”
BackgroundFundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy
Rangel Rivera, G. O., Knochelmann, H. M., Dwyer, C. J., Smith, A. S., Wyatt, M. M., Rivera-Reyes, A. M., Thaxton, J. E., & Paulos, C. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.645242 · Cited by 140
“Collectively this body work suggests that PD-1/PDL1 blockade can bolster T cell glycolysis to support their antitumor activity (84, 114).”
BackgroundSormendi, S., & Wielockx, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00040 · Cited by 141
Ketolysis drives CD8+ T cell effector function through effects on histone acetylation
Luda, K. M., Longo, J., Kitchen-Goosen, S. M., Duimstra, L. R., Ma, E. H., Watson, M. J., Oswald, B. M., Fu, Z., Madaj, Z., Kupai, A., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.07.002 · Cited by 140
Exhaustion of T lymphocytes in the tumor microenvironment: Significance and effective mechanisms
Gholami, M. D., Kardar, G. A., Saeedi, Y., Heidari, S., Garssen, J., & Falak, R. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.10.002 · Cited by 161
Competitive glucose metabolism as a target to boost bladder cancer immunotherapy
Afonso, J., Santos, L. L., Longatto‐Filho, A., & Baltazar, F. (2020) · Nature Reviews Urology · doi:10.1038/s41585-019-0263-6 · Cited by 144
Hossain, M. A., Liu, G., Dai, B., Si, Y., Yang, Q., Wazir, J., Birnbaumer, L., & Yang, Y. (2020) · Medicinal Research Reviews · doi:10.1002/med.21727 · Cited by 154
Functional Expression of Programmed Death-Ligand 1 (B7-H1) by Immune Cells and Tumor Cells
Gibbons Johnson, R. M., & Dong, H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00961 · Cited by 129
“Naïve CD8+ T cells utilize oxidative phosphorylation, but upon activation CD8+ T cells make a metabolic switch and primarily rely upon the less efficient metabolic program of glycolysis (87, 88).”
BackgroundThe Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer
van Dijk, N., Funt, S. A., Blank, C. U., Powles, T. B., Rosenberg, J. E., & van der Heijden, M. S. (2018) · European Urology · doi:10.1016/j.eururo.2018.09.022 · Cited by 125
Radiotherapy induced immunogenic cell death by remodeling tumor immune microenvironment
Zhu, S., Wang, Y., Tang, J., & Cao, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1074477 · Cited by 155
“Glucose deficiency leads to a decrease in glycolysis in immune cells, which hinders IFN-g production and the function of CTLs (47).”
BackgroundMatias, M. I., Yong, C. S. M., Foroushani, A. B. K., Goldsmith, C., Mongellaz, C., Sezgin, E., Levental, K. R., Talebi, A., Perrault, J., Riviere, A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109911 · Cited by 132
Metabolic reprogramming of human CD8+ memory T cells through loss of SIRT1
Jeng, M. Y., Hull, P. A., Fei, M., Kwon, H.-S., Tsou, C.-L., Kasler, H., Ng, C.-P., Gordon, D. E., Johnson, J., Krogan, N., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20161066 · Cited by 121
“4 E) as reported by others (Cham et al., 2008; Chang et al., 2013), further linking glycolytic and cytotoxic capacities of CD8+ T cells under resting conditions.”
BackgroundDistinct metabolic programs in activated T cells: opportunities for selective immunomodulation
Wahl, D. R., Byersdorfer, C. A., Ferrara, J. L. M., Opipari, A. W., & Glick, G. D. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01148.x · Cited by 132
“5 mM decreases effector CD8 T-cell proliferation by fourfold (36) and similar reductions decrease IFN-c production by 80% (37).”
BackgroundModulation of mTOR Signalling Triggers the Formation of Stem Cell-like Memory T Cells
Scholz, G., Jandus, C., Zhang, L., Grandclément, C., Lopez-Mejia, I. C., Soneson, C., Delorenzi, M., Fajas, L., Held, W., Dormond, O., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.01.019 · Cited by 121
GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma
Sun, H.-W., Yu, X.-J., Wu, W.-C., Chen, J., Shi, M., Zheng, L., & Xu, J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0168907 · Cited by 120
Enhanced oxidative phosphorylation in NKT cells is essential for their survival and function
Kumar, A., Pyaram, K., Yarosz, E. L., Hong, H. S., Lyssiotis, C. A., Giri, S., & Chang, C. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901376116 · Cited by 129
“materials to support proliferation and this shift regulates the acquisition of effector function in certain T cell subsets (25, 42).”
BackgroundDiet, lipids, and antitumor immunity
Prendeville, H., & Lynch, L. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00781-x · Cited by 134
“High levels of exogenous glucose are imperative to sustain the transcription of glycolytic machinery and effector cytokines [64, 65].”
BackgroundThe influence of microenvironment on tumor immunotherapy
Zhang, J., Shi, Z., Xu, X., Yu, Z., & Mi, J. (2019) · FEBS Journal · doi:10.1111/febs.15028 · Cited by 118
Wegorzewska, M. M., Glowacki, R. W. P., Hsieh, S. A., Donermeyer, D. L., Hickey, C. A., Horvath, S. C., Martens, E. C., Stappenbeck, T. S., & Allen, P. M. (2019) · Science Immunology · doi:10.1126/sciimmunol.aau9079 · Cited by 107
Metadata
- Authors
- Cham, C. M., Driessens, G., O'Keefe, J. P., & Gajewski, T. F.
- Affiliations
- University of Chicago (US)
- Corresponding author
- Gajewski, Thomas F.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2008-09
- Volume
- 38
- Issue
- 9
- Pages
- 2438-2450
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- PMC
- PMC3008428
- OpenAlex
- W2156145814
- Cited by
- 388
- References
- 33
- Citations by year
- 2026: 21 · 2025: 28 · 2024: 34 · 2023: 42 · 2022: 34 · 2021: 35 · 2020: 42 · 2019: 24 · 2018: 22 · 2017: 29 · 2016: 21 · 2015: 15 · 2014: 10 · 2013: 8 · 2012: 10
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01 AI47919, R01AI047919)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- glucose deprivation, CD8+ T cells, effector T cells, glycolysis, 2-deoxyglucose, glucose metabolism, interferon-gamma, GM-CSF, granzyme B, cytotoxicity, gene expression, cell cycle progression, cyclin D2, oxygen deprivation, solid tumors, cell-mediated immunity
- MeSH terms
- Animals, Cytotoxicity, Immunologic, Deoxyglucose, Glucose, Lymphocyte Activation, Oxygen, Gene Expression, Cytokines, CD8-Positive T-Lymphocytes, Gene Expression Profiling, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.